Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

A continuous glucose monitor is a better option than pricking your finger daily. These wearable devices are stuck to your arm and connect to an app on your smartphone or Apple Watch to easily test ...

Dexcom, Inc., the world leader in real-time Continuous Glucose Monitoring (CGM) for people with diabetes, recently announced the launch of the Dexcom G6 mobile app in Spanish, available for download ...

Medicare Part B typically covers continuous glucose monitors (CGMs) like the Dexcom G7, as they are Food and Drug Administration (FDA)-approved durable medical equipment items. To get a Dexcom G7 CGM ...

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

A screenshot from an urgent field safety notice of a diagram showing the Dexcom G6 receiver. Dexcom (Nasdaq:DXCM) recently issued an urgent field safety notice in Europe warning of a potential issue ...

Monitoring your blood sugar levels is crucial for effective diabetes management. It helps you understand how different factors, such as diet and exercise, impact your blood sugar range. A healthy ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...

– Only Automated Insulin Delivery System in Canada to Feature Both Dexcom G7 and G6 CGM Technology Now Authorized for Sale by Health Canada – MARKHAM, Ontario, July 29, 2024--(BUSINESS WIRE)--Tandem ...

For people with diabetes, continuously monitoring blood glucose levels offers invaluable health insights. But this advanced technology comes at a price. So, what is the cost for a Dexcom continuous ...